Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Chikungunya Infection in Neonates: Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous Immunoglobulins

NCT02230163 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de la Guadeloupe as lead sponsor.

NCT NCT02230163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02230163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Chikungunya Infection in Neonates: Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous Immunoglobulins
Lead sponsor
Centre Hospitalier Universitaire de la Guadeloupe
Phase
Phase 1/2
Overall status
Unknown status
Start date
September 30, 2014
Completion date
April 30, 2016
Enrollment
40 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chikungunya virus infection